Kaleido Biosciences, Inc. (KLDO) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 31 transactions totaling $33.0M, demonstrating a bullish sentiment with $33.0M in net insider flow. The most recent transaction on Feb 28, 2022 involved a transaction of 2,046 shares valued at $3.0K.
No significant insider buying has been recorded for KLDO in the recent period.
No significant insider selling has been recorded for KLDO in the recent period.
Based on recent SEC filings, insider sentiment for KLDO is bullish with an Insider Alignment Score of 100/100 and a net flow of $33.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Kaleido Biosciences, Inc. (KLDO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading KLDO stock, having executed 31 transactions in the past 90 days. The most active insider is Ventures Opportunities Fund I, L.p. Flagship (Executive), who has made 3 transactions totaling $15.0M.
Get notified when executives and directors at KLDO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Korn Jerald | Executive | Payment | 2,046 | $1.49 | $3.0K | |
| Feb 28, 2022 | Vlieg Johan Van Hylckama | Executive | Payment | 2,087 | $1.49 | $3.1K | |
| Feb 8, 2021 | Ltp Fund, L.p. Nutritional Health | Executive | Purchase | 71,667 | $11.50 | $824.2K | Large |
| Feb 8, 2021 | Ltp Fund, L.p. Nutritional Health | Executive | Purchase | 71,667 | $11.50 | $824.2K | Large |
| Feb 8, 2021 | Ltp Fund, L.p. Nutritional Health | Executive | Purchase | 71,666 | $11.50 | $824.2K | Large |
| Feb 8, 2021 | L. Menichella Daniel | Executive | Purchase | 20,000 | $11.50 | $230.0K | |
| Jun 4, 2020 | Theo Melas Kyriazi | Executive | Purchase | 33,333 | $7.50 | $250.0K | |
| Jun 4, 2020 | Opportunities Fund I, L.p. Flagship Ventures | Executive | Purchase | 666,667 | $7.50 | $5.0M | Large |
| Jun 4, 2020 | Opportunities Fund I, L.p. Flagship Ventures | Executive | Purchase | 666,667 | $7.50 | $5.0M | Large |
| Jun 4, 2020 | Opportunities Fund I, L.p. Flagship Ventures | Executive | Purchase | 666,666 | $7.50 | $5.0M | Large |
| Mar 4, 2019 | Geoffrey Von Maltzahn | Executive | Conversion | 342,466 | $N/A | $0 | |
| Mar 4, 2019 | G. Quinn Anthony | Executive | Conversion | 12,853 | $N/A | $0 | |
| Mar 4, 2019 | W. Bonney Michael | Executive | Conversion | 225,000 | $N/A | $0 | |
| Mar 4, 2019 | W. Bonney Michael | Executive | Conversion | 417,673 | $N/A | $0 | |
| Mar 4, 2019 | Afeyan Noubar | Executive | Conversion | 665,908 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 13 | $33.0M | 100.0% |
Payment(F) | 2 | $6.2K | 0.0% |
Conversion(C) | 16 | $0 | 0.0% |
Insiders at Kaleido Biosciences, Inc. are accumulating shares at an accelerated pace. With 11 insiders making 31 transactions totaling $33.0M in purchases versus $0 in sales, the net buying activity of $33.0M signals strong executive confidence. Ventures Opportunities Fund I, L.p. Flagship (Executive) leads the buying activity with $15.0M in transactions across all time.